Formulation for the Targeted Delivery of a Vaccine Strain of Oncolytic Measles Virus (OMV) in Hyaluronic Acid Coated Thiolated Chitosan as a Green Nanoformulation for the Treatment of Prostate Cancer: A Viro-Immunotherapeutic Approach [Retraction] | Health & Environmental Research Online (HERO)

Health & Environmental Research Online (HERO)

Print Feedback Export to File

This record has one attached file:

Citation
Tags

HERO ID

11910278

Reference Type

Journal Article

Subtype

Retraction

Title

Formulation for the Targeted Delivery of a Vaccine Strain of Oncolytic Measles Virus (OMV) in Hyaluronic Acid Coated Thiolated Chitosan as a Green Nanoformulation for the Treatment of Prostate Cancer: A Viro-Immunotherapeutic Approach [Retraction]

Year

2024

Is Peer Reviewed?

Yes

Journal

International Journal of Nanomedicine
ISSN: 1176-9114
EISSN: 1178-2013

Volume

Page Numbers

5719-5720

Language

English

PMID

38895151

DOI

10.2147/IJN.S482137

Relationship(s)

is retraction of 11885849 Formulation for the Targeted Delivery of a Vaccine Strain of Oncolytic Measles Virus (OMV) in Hyaluronic Acid Coated Thiolated Chitosan as a Green Nanoformulation for the Treatment of Prostate Cancer: A Viro-Immunotherapeutic Approach

Abstract

[This retracts the article DOI: 10.2147/IJN.S386560.].